Related Experiment Video
Updated: Feb 25, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
MicroRNA-150 as a Potential Biomarker in Diagnosis of Cancer: a Meta-Analysis
Background:
Altered expression of microRNAs contributes to human carcinogenesis. Previous studies assessed the association of aberrant circulating microRNA (miR)-150 level with the risk in developing various human cancers, but the data were inconsistent.
Methods:
This meta-analysis further assessed the potential diagnostic value of miR-150 in cancer. PubMed, Embase, and Web of Science for publications were searched using the keywords of miR-150 and human cancer. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were obtained to assess the diagnostic value.
Results:
The summary estimates revealed that the pooled sensitivity was 80% (95% CI: 74% - 85%), the specificity was 81% (95% CI: 71% - 87%), the DOR was 16.47 (95% CI: 10.41 - 26.06), and the AUC was 0.86 (95% CI: 0.82 - 0.89) for miR-150 as a tumor marker.
Conclusions:
miR-150 may be a potential noninvasive tumor marker for various human cancers and further studies with a large sample size are needed to confirm.
Insights
MicroRNA (miR)-150 shows potential as a noninvasive biomarker for various cancers. This meta-analysis confirms its diagnostic value, with high sensitivity and specificity for cancer detection.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- MicroRNAs (miRNAs) play a role in human cancer development.
- Previous research on circulating miR-150 levels and cancer risk yielded inconsistent results.
Purpose of the Study:
- To evaluate the diagnostic accuracy of miR-150 as a biomarker for human cancers.
- To consolidate existing evidence through a meta-analysis.
Main Methods:
- A systematic literature search was conducted across PubMed, Embase, and Web of Science.
- Keywords used included "miR-150" and "human cancer".
- Diagnostic value was assessed using pooled sensitivity, specificity, diagnostic odds ratio (DOR), and area under the curve (AUC).
Main Results:
- The meta-analysis demonstrated a pooled sensitivity of 80% and specificity of 81% for miR-150.
- The diagnostic odds ratio (DOR) was 16.47.
- The area under the curve (AUC) was 0.86, indicating good diagnostic performance.
Conclusions:
- Circulating miR-150 shows promise as a noninvasive tumor marker for multiple human cancers.
- Further large-scale studies are warranted to validate these findings.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs